SpineGuard

As of December 31, 2025, SpineGuard carries a market capitalization of 9.01M, placing it among publicly traded companies globally. Its enterprise value stands at 8.74M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

SpineGuard's next confirmed earnings release is scheduled for April 15, 2027.

As of December 31, 2025, SpineGuard has 89.19M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, SpineGuard maintains a current ratio of 1.75, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 23, 2026, SpineGuard's stock has declined approximately 35.00% over the past 52 weeks. The 50-day moving average sits at 0.10, while the 200-day moving average is 0.10.

As of December 31, 2025, SpineGuard holds 1.72M in cash and equivalents against 1.46M in total debt, resulting in a net debt position of -495,032.00. Total book value stands at 5.47M, with working capital of 1.49M providing operational flexibility.

SpineGuard's most recent stock split took place on December 9, 2025.